Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRANOXY2016: Tranexamic Acid vs Oxytocin for PPH Prevention
NCT02775773Phase 3Completed
- Sponsor
- Azienda USL 1 di Massa e Carrara
- Start
- Jan 2018
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tranexamic acid in postpartum hemorrhage (PPH) (2 arms), sponsored by Azienda USL 1 di Massa e Carrara. Primary endpoints: Total blood loss immediately after delivery and Total blood loss two hours after delivery. Started Jan 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on NCT02775773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02775773.